Twenty-nine patients were examined by study neurologists within 7 days of weakness onset; 2 patients were evaluated on days 11 and 18 after weakness onset, respectively, and initial neurologic findings for 1 patient were obtained by personal communication (T. Clark, Colorado Pulmonary Associates, Denver, CO, USA).
The median survival is only 4.5 months, and survival is strongly correlated with initial neurologic disability, similar to the general population with stroke.
Initial neurologic severity parallels the severity of pulmonary disease and is predictive of neurologic outcomes.
On initial evaluation the patient was noted to be alert and oriented, and to have "an isolated injury to the left eye and orbit area with normal neurologic exam".
Adjunctive steroids reduce mortality, but may have no effect on disabling neurologic deficits in survivors.
On arrival, neurologic examination revealed decreased alertness, dysarthria, and ataxia.
Subjects had no clinically significant medical or neurologic conditions, and no clinically significant abnormalities on physical, neurologic, or laboratory examinations.
We found no pattern of abnormalities on medical, neurologic, neuropsychologic, or NES-2 evaluation.
The greatest postresuscitation emphasis has mainly been on preserving neurologic function [ 8].
The results on the neurologic examination are reported as percentage of children with nonoptimal function.
